AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 283: R1386-R1394, 2002. First published September 5, 2002; doi:10.1152/ajpregu.00324.2002
0363-6119/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/6/R1386    most recent
00324.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryall, J. G.
Right arrow Articles by Lynch, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryall, J. G.
Right arrow Articles by Lynch, G. S.
Vol. 283, Issue 6, R1386-R1394, December 2002

beta 2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol

James G. Ryall1, Paul Gregorevic1, David R. Plant1, Martin N. Sillence2, and Gordon S. Lynch1

1 Department of Physiology, The University of Melbourne, Melbourne, Victoria 3010; and 2 School of Agriculture, Charles Sturt University, Wagga Wagga, New South Wales 2678, Australia

Potential treatments for skeletal muscle wasting and weakness ideally possess both anabolic and ergogenic properties. Although the beta 2-adrenoceptor agonist clenbuterol has well-characterized effects on skeletal muscle, less is known about the therapeutic potential of the related beta 2-adrenoceptor agonist fenoterol. We administered an equimolar dose of either clenbuterol or fenoterol to rats for 4 wk to compare their effects on skeletal muscle and tested the hypothesis that fenoterol would produce more powerful anabolic and ergogenic effects. Clenbuterol treatment increased fiber cross-sectional area (CSA) by 6% and maximal isometric force (Po) by 20% in extensor digitorum longus (EDL) muscles, whereas fiber CSA in soleus muscles decreased by 3% and Po was unchanged, compared with untreated controls. In the EDL muscles, fenoterol treatment increased fiber CSA by 20% and increased Po by 12% above values achieved after clenbuterol treatment. Soleus muscles of fenoterol-treated rats exhibited a 13% increase in fiber CSA and a 17% increase in Po above that of clenbuterol-treated rats. These data indicate that fenoterol has greater effects on the functional properties of rat skeletal muscles than clenbuterol.

beta -adrenoceptor; fiber type; skeletal muscle; hypertrophy; muscle wasting; plasticity; muscle contraction


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
J. G. Ryall, J. D. Schertzer, T. M. Alabakis, S. M. Gehrig, D. R. Plant, and G. S. Lynch
Intramuscular {beta}2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury
J Appl Physiol, July 1, 2008; 105(1): 165 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Beitzel, M. N. Sillence, and G. S. Lynch
beta-Adrenoceptor signaling in regenerating skeletal muscle after beta-agonist administration
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E932 - E940.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. G. Ryall, J. D. Schertzer, and G. S. Lynch
Attenuation of Age-Related Muscle Wasting and Weakness in Rats After Formoterol Treatment: Therapeutic Implications for Sarcopenia
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2007; 62(8): 813 - 823.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
W. O. Kline, F. J. Panaro, H. Yang, and S. C. Bodine
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
J Appl Physiol, February 1, 2007; 102(2): 740 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
J. G. Burniston, L.-B. Tan, and D. F. Goldspink
Relative myotoxic and haemodynamic effects of the {beta}-agonists fenoterol and clenbuterol measured in conscious unrestrained rats
Exp Physiol, November 1, 2006; 91(6): 1041 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A.-M. Axell, H. E. MacLean, D. R. Plant, L. J. Harcourt, J. A. Davis, M. Jimenez, D. J. Handelsman, G. S. Lynch, and J. D. Zajac
Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E506 - E516.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch
Chronic {beta}-agonist administration affects cardiac function of adult but not old rats, independent of {beta}-adrenoceptor density
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H344 - H349.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Busquets, M. T. Figueras, G. Fuster, V. Almendro, R. Moore-Carrasco, E. Ametller, J. M. Argiles, and F. J. Lopez-Soriano
Anticachectic Effects of Formoterol: A Drug for Potential Treatment of Muscle Wasting
Cancer Res., September 15, 2004; 64(18): 6725 - 6731.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
F. Beitzel, P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch
{beta}2-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury
J Appl Physiol, April 1, 2004; 96(4): 1385 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. G. Ryall, D. R. Plant, P. Gregorevic, M. N. Sillence, and G. S. Lynch
{beta}2-Agonist administration reverses muscle wasting and improves muscle function in aged rats
J. Physiol., February 15, 2004; 555(1): 175 - 188.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online